A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location. In addition, following initial curative therapy, many patients present with limited...
Main Authors: | Pretesh R. Patel, David S. Yoo, Yuzuru Niibe, James J. Urbanic, Joseph K. Salama |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/480961 |
Similar Items
-
Oligometastases/Oligo-Recurrence of Lung Cancer
by: Yuzuru Niibe, et al.
Published: (2013-01-01) -
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
by: Daniel R. Gomez, et al.
Published: (2012-01-01) -
Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
by: Yuzuru Niibe, et al.
Published: (2012-01-01) -
Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
by: Wataru Takahashi, et al.
Published: (2012-01-01) -
Radiotherapy for Oligometastatic Lung Cancer
by: Derek P. Bergsma, et al.
Published: (2017-09-01)